Dan Su

1.6k total citations
42 papers, 719 citations indexed

About

Dan Su is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Dan Su has authored 42 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Dan Su's work include DNA Repair Mechanisms (10 papers), CRISPR and Genetic Engineering (8 papers) and Ubiquitin and proteasome pathways (5 papers). Dan Su is often cited by papers focused on DNA Repair Mechanisms (10 papers), CRISPR and Genetic Engineering (8 papers) and Ubiquitin and proteasome pathways (5 papers). Dan Su collaborates with scholars based in United States, China and Ireland. Dan Su's co-authors include Junjie Chen, Mengfan Tang, Chao Wang, Xu Feng, Huimin Zhang, Zhen Chen, Litong Nie, Yun Xiong, Traver Hart and Mrinal Srivastava and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Dan Su

38 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Su United States 16 517 246 101 67 57 42 719
Deepak Perumal United States 14 529 1.0× 209 0.8× 86 0.9× 108 1.6× 35 0.6× 33 714
Luis A. Carvajal United States 10 550 1.1× 354 1.4× 120 1.2× 134 2.0× 33 0.6× 29 814
Aaron Nguyen United States 12 695 1.3× 207 0.8× 80 0.8× 65 1.0× 79 1.4× 21 966
Boaz Nachmias Israel 11 451 0.9× 185 0.8× 112 1.1× 87 1.3× 60 1.1× 57 697
Liz J. Valente Australia 12 680 1.3× 443 1.8× 95 0.9× 180 2.7× 43 0.8× 13 884
Mathieu Lajoie Canada 14 399 0.8× 158 0.6× 96 1.0× 139 2.1× 30 0.5× 24 712
Julie L.C. Kan United States 18 778 1.5× 227 0.9× 55 0.5× 118 1.8× 39 0.7× 24 1.0k
Isha Kapoor India 13 376 0.7× 141 0.6× 60 0.6× 81 1.2× 107 1.9× 25 569
Milena Vuica‐Ross United States 12 465 0.9× 130 0.5× 93 0.9× 74 1.1× 27 0.5× 20 679
Yoshihito Kano Japan 12 491 0.9× 266 1.1× 177 1.8× 99 1.5× 19 0.3× 29 763

Countries citing papers authored by Dan Su

Since Specialization
Citations

This map shows the geographic impact of Dan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Su more than expected).

Fields of papers citing papers by Dan Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Su. The network helps show where Dan Su may publish in the future.

Co-authorship network of co-authors of Dan Su

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Su. A scholar is included among the top collaborators of Dan Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Su. Dan Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Moure, Casey J., Brandon Vara, Mangeng Cheng, et al.. (2024). Activation of Hepatocyte Growth Factor/MET Signaling as a Mechanism of Acquired Resistance to a Novel YAP1/TEAD Small Molecule Inhibitor. Molecular Cancer Therapeutics. 23(8). 1095–1108. 5 indexed citations
3.
Yu, Lili, Feifei Gao, Yaoxin Li, et al.. (2024). Role of pattern recognition receptors in the development of MASLD and potential therapeutic applications. Biomedicine & Pharmacotherapy. 175. 116724–116724. 15 indexed citations
4.
Ma, Ming, Chao Liu, Dan Su, et al.. (2024). Dynamic radiological features predict pathological response after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma. Journal of Translational Medicine. 22(1). 471–471. 4 indexed citations
5.
Su, Dan, et al.. (2024). Fraxinellone alleviates colitis-related intestinal fibrosis by blocking the circuit between PD-1+ Th17 cells and fibroblasts. International Immunopharmacology. 135. 112298–112298. 1 indexed citations
6.
Zhang, Huimin, Yun Xiong, Yilun Sun, et al.. (2023). RAD54L2-mediated DNA damage avoidance pathway specifically preserves genome integrity in response to topoisomerase 2 poisons. Science Advances. 9(49). eadi6681–eadi6681. 9 indexed citations
7.
Li, Ningning, Dan Su, Shan Sun, et al.. (2023). Chlorpromazine affects autophagy in association with altered Rag GTPase–mTORC1–TFEB signaling. Frontiers in Cell and Developmental Biology. 11. 1266198–1266198. 3 indexed citations
8.
Li, Dong, et al.. (2022). Research Progress on the Extraction Technology of Seabuckthorn Fruit Oil and the Application of Nutritional Factors. SHILAP Revista de lepidopterología. 3 indexed citations
9.
Feng, Xu, Mengfan Tang, Merve Dede, et al.. (2022). Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors. Science Advances. 8(19). eabm6638–eabm6638. 25 indexed citations
10.
Nie, Litong, Chao Wang, Nan Li, et al.. (2020). Proteome-wide Analysis Reveals Substrates of E3 Ligase RNF146 Targeted for Degradation. Molecular & Cellular Proteomics. 19(12). 2015–2030. 13 indexed citations
11.
Su, Dan, Xu Feng, Medina Colic, et al.. (2020). CRISPR/CAS9-based DNA damage response screens reveal gene-drug interactions. DNA repair. 87. 102803–102803. 26 indexed citations
12.
Srivastava, Mrinal, Dan Su, Huimin Zhang, et al.. (2020). HMCES safeguards replication from oxidative stress and ensures error‐free repair. EMBO Reports. 21(6). e49123–e49123. 28 indexed citations
13.
Wang, Chao, Zhen Chen, Litong Nie, et al.. (2020). Extracellular signal-regulated kinases associate with and phosphorylate DHPS to promote cell proliferation. Oncogenesis. 9(9). 85–85. 7 indexed citations
14.
Chen, Zhen, Chao Wang, Antrix Jain, et al.. (2020). AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. Molecular & Cellular Proteomics. 19(3). 467–477. 15 indexed citations
16.
Zhang, Fanrong, Lisha Ying, Jiaoyue Jin, et al.. (2018). GAP43, a novel metastasis promoter in non-small cell lung cancer. Journal of Translational Medicine. 16(1). 310–310. 17 indexed citations
17.
Wu, Xiao Y., Ling Wu, Jianxin Liu, et al.. (2017). Abro1 maintains genome stability and limits replication stress by protecting replication fork stability. Genes & Development. 31(14). 1469–1482. 53 indexed citations
18.
Wu, Qian, Atanu Paul, Dan Su, et al.. (2016). Structure of BRCA1-BRCT/Abraxas Complex Reveals Phosphorylation-Dependent BRCT Dimerization at DNA Damage Sites. Molecular Cell. 61(3). 434–448. 59 indexed citations
19.
Zhang, Tingting, Dan Su, Juan Li, et al.. (2015). [Clinical efficacy observation of cetuximab combined with chemotherapy in the treatment of metastatic colorectal carcinoma].. PubMed. 18(6). 584–8. 1 indexed citations
20.
Shao, Lan, Dan Su, Fajun Xie, et al.. (2012). Analysis of efficacy and survival of patients receiving second-line treatment for sensitive recurrent small-cell lung cancer. Tumori. 32(11). 892–898. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026